(PDF) Mitomycin C and Vinorelbine for Second-Line

Mitomycin C and Vinorelbine for Second-Line Chemotherapy in NSCLC – A Phase II Trial

British Journal of Cancer - United Kingdom

doi 10.1038/sj.bjc.6603683

Full Text

Abstract

Available in full text

Categories

Cancer Research

Date

March 13, 2007

Authors

Publisher

Springer Science and Business Media LLC

Related search

Gemcitabine Plus Vinorelbine as First-Line Chemotherapy in Advanced Nonsmall Cell Lung Carcinoma a Phase II Trial

Cancer Research

English

P1.01-90 a Pilot Trial Assessing Apatinib Combined With Docetaxel (DTX) as Second-Line Chemotherapy for EGFR Negative Advanced NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

Anticancer Research

Cancer Research

English

Karnofsky-Adapted Chemotherapy of Non Small Cell Lung Cancer (NSCLC) With Ifosfamide/Mitomycin C/Vindesine

Journal of Cancer Research and Clinical Oncology

Cancer Research

English

PCN37 Cost-Minimization Analysis of Second-Line Chemotherapy for Non-Small-Cell Lung Cancer (NSCLC)

Value in Health

Occupational Health

English

Phase II Study of Vinorelbine and Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer as Frontline and Second-Line Therapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Cancer Research

English

Vinorelbine and Gemcitabine as Second- Or Third-Line Therapy for Malignant Pleural Mesothelioma

Cancer Research

Respiratory Medicine

English

Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy

British Journal of Cancer

Cancer Research

English

194TiP: LUNAR: Phase III Study of Front-Line Chemotherapy With TTFields for Advanced Squamous NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English